After-hours 17:18 (ET)KPTI Latest Quarter’s Earnings
Announce Date8/13/2026
EPS Actual (USD)-2.32
Revenue Actual (USD)33.43M
Karyopharm Therapeutics Inc Earnings Dates & Reports
This page offers detailed Karyopharm Therapeutics Inc earnings data including the latest Karyopharm Therapeutics Inc earnings report, the upcoming Karyopharm Therapeutics Inc earnings date, historical data and Karyopharm Therapeutics Inc earnings call news.
KPTI Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
KPTI FY2025 Earnings
EPS (YoY)-17.93-90.58%
Revenue (YoY)146.07M0.57%
Karyopharm Therapeutics Inc (KPTI) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/13/2026 | 06/2026 | -2.32/-1.28 | 33.43M/32.19M | -81.42% | 3.87% |
| 5/14/2026 | 03/2026 | -1.02/-1.43 | 35.07M/31.40M | 28.80% | 11.68% |
| 2/12/2026 | 12/2025 | -5.68/-1.99 | 34.08M/35.11M | -185.03% | -2.94% |
| 11/3/2025 | 09/2025 | -3.82/-3.13 | 44.04M/41.21M | -22.07% | 6.87% |
| 8/11/2025 | 06/2025 | -4.32/-4.10 | 37.93M/36.94M | -5.44% | 2.69% |
| 5/12/2025 | 03/2025 | -2.77/-4.18 | 30.02M/35.24M | 33.74% | -14.83% |
| 2/19/2025 | 12/2024 | -3.67/-3.92 | 30.54M/34.86M | 6.50% | -12.40% |
| 11/5/2024 | 09/2024 | -3.85/-3.94 | 38.78M/37.79M | 2.40% | 2.63% |
Karyopharm Therapeutics Inc Latest Earnings Call Transcripts
Karyopharm (KPTI) Q2 2026 Earnings Call: Selinexor sNDA and Liquidity Focus
Karyopharm’s Q2 2026 earnings call covered $33.4 million in revenue, an August selinexor sNDA target, reaffirmed guidance and near-term liquidity risk.